Focal therapy IDEAL Prostate cancer

5-alpha Reductase Inhibitors Humans Male Oxidoreductases Prospective Studies *Prostatic Hyperplasia/drug therapy *Prostatic Neoplasms/drug therapy 5?-reductase inhibitors Bph Prostate cancer cancer specific mortality meta-analysis

Prostatic arterial embolization transurethral resection of the prostate benign prostatic hyperplasia meta-analysis

Lasers bipolar technology benign prostatic enlargement systematic review meta-analysis

Humans Lasers Solid-State *Learning Curve Male *Postoperative Complications/epidemiology Prostatectomy Prostatic Hyperplasia/complications Treatment Outcome Urinary Bladder Neck Obstruction/etiology *Benign prostatic hyperplasia *Complicaciones *Complications *Curva de aprendizaje *Hiperplasia prostática benigna *HoLEP *Laser *Láser *Prostate *Próstata

Bcg Instillation Intravesical Low dose Non–muscle-invasive bladder cancer

膀胱肿瘤 根治性膀胱切除术 机器人 剖腹术 Meta分析

窄带成像 非肌层浸润性膀胱癌 经尿道膀胱肿瘤电切术 安全性 共识

Cystectomy/*methods Humans Perioperative Care/*methods Postoperative Complications/epidemiology/prevention & control *Recovery of Function Standard of Care Urinary Bladder Neoplasms/*surgery Urologic Surgical Procedures/*methods

Biomarkers Tumor/*urine Fibronectins/*urine Humans Prognosis Urinary Bladder Neoplasms/*diagnosis/urine Biomarker Bladder cancer Diagnosis Meta-analysis Urine fibronectin standards of institutional and international research committee this article is based on previous published studies thus it does not contain any studies with human participants or animals. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Acetylation Arylamine N-Acetyltransferase/*genetics/metabolism Asian People/genetics Case-Control Studies China/epidemiology Genetic Association Studies Genetic Predisposition to Disease Humans Odds Ratio Phenotype *Polymorphism Single Nucleotide Risk Assessment Risk Factors Urinary Bladder Neoplasms/enzymology/ethnology/*genetics

Antibiotics Antineoplastic/*therapeutic use BCG Vaccine/*therapeutic use Combined Modality Therapy Humans Mitomycin/*therapeutic use Urinary Bladder Neoplasms/*drug therapy bacillus Calmette-Guérin mitomycin C non-muscle-invasive bladder carcinoma recurrence rate meta-analysis.